1 |
0.12% saline |
- |
- |
- |
- |
299 [1] 299 💬 |
2 |
0.9% isotonic saline (is) |
- |
- |
- |
- |
299 [1] 299 💬 |
3 |
0.9% isotonic saline (is), 4ml |
- |
- |
- |
- |
299 [1] 299 💬 |
4 |
0.9% normal saline (control) |
- |
- |
- |
- |
299 [1] 299 💬 |
5 |
0.9% physiological saline |
- |
- |
- |
- |
266 [1] 266 💬 |
6 |
0.9% saline |
- |
- |
- |
- |
070 [1] 70 💬 |
7 |
0.9% sodium chloride (normal saline) |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [1] 6 💬 |
8 |
2-{7-[1,1-dimethyl-3-(4-sulfobutyl)-benz[e]indolin-2-ylidene]-1,3,5-heptatrienyl}-1,1-dimethyl-3-(sulfobutyl)-1h-benz[e]-indolium hydroxide,inner salt |
Hydroxide ion |
- |
- |
- |
046 [1] 46 💬 |
9 |
3-[4-(1h-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(n-butyloxylcarbamate)-sulphonamide] sodium salt |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
10 |
5-amino salicylic acid |
Salicylic acid |
[1] D00097 D00097 💬 |
- |
- |
097 [1] 97 💬 |
11 |
5-amino salicylic acid (5-asa) |
Mesalazine |
[2] D00097 D00097, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
12 |
6% hypertonic saline (hs), 4ml |
- |
- |
- |
- |
299 [1] 299 💬 |
13 |
7% hypertonic saline (hs) |
- |
- |
- |
- |
299 [1] 299 💬 |
14 |
7% saline |
- |
- |
- |
- |
299 [1] 299 💬 |
15 |
[tolvaptan 15] |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
16 |
[tolvaptan 30] |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
17 |
[tolvaptan 45/15] |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
18 |
Aav1-gamma-sarcoglycan vector injection |
- |
- |
- |
- |
113 [1] 113 💬 |
19 |
Abr-215062 sodium salt |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
20 |
Acetazolamide sandoz 250 |
Acetazolamide |
[2] D00218 D00218, D01196 D01196 💬 |
CA1 [13] CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 |
Bile secretion [7] Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation |
225 [1] 225 💬 |
21 |
Active treatment group 7% hypertonic saline |
- |
- |
- |
- |
299 [1] 299 💬 |
22 |
Alirocumab sar236553 (regn727) |
Alirocumab |
[1] D10335 D10335 💬 |
PCSK9 [1] PCSK9 💬 |
Cholesterol metabolism [1] Cholesterol metabolism |
079 [1] 79 💬 |
23 |
Allopurinol sandoz 100 mg, tabletten |
Allopurinol |
[1] D00224 D00224 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 [1] 96 💬 |
24 |
Amitriptyline, fluoxetine and tramadol alone (control group) |
Amitriptyline |
[6] D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D07448 D07448, D08623 D08623 💬 |
OPRM1 [3] OPRM1, SLC6A2, SLC6A4 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
078 [1] 78 💬 |
25 |
Amorphous calcium carbonate |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
235 [1] 235 💬 |
26 |
Anti-tnf discontinuation: physiological saline solution |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
27 |
Arthroscopy & saline irrigation alone |
- |
- |
- |
- |
046 [1] 46 💬 |
28 |
Artificial saliva |
- |
- |
- |
- |
053 [1] 53 💬 |
29 |
Atg+cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
30 |
Atg+rapamune+cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
31 |
Behavioral: increased dietary intake of salmon or cod |
Salmon, unspecified |
- |
- |
- |
097 [1] 97 💬 |
32 |
Benazepril |
Benazepril |
[2] D00620 D00620, D07499 D07499 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
049 [4] 49, 57, 218, 224 💬 |
33 |
Benazepril hydrochloride tablets |
Benazepril |
[2] D00620 D00620, D07499 D07499 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
224 [1] 224 💬 |
34 |
Benazepril pill |
Benazepril |
[2] D00620 D00620, D07499 D07499 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
049 [1] 49 💬 |
35 |
Benazepril, valsartan and fluvastatin |
Benazepril |
[5] D00400 D00400, D00620 D00620, D00892 D00892, D07499 D07499, D07983 D07983 💬 |
ACE [3] ACE, AGTR1, HMGCR 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
218 [1] 218 💬 |
36 |
Biological sampling |
- |
- |
- |
- |
065 [1] 65 💬 |
37 |
Biological samplings |
- |
- |
- |
- |
096 [1] 96 💬 |
38 |
Biopsy of the labial salivary gland |
- |
- |
- |
- |
053 [1] 53 💬 |
39 |
Blood and stools samples |
- |
- |
- |
- |
096 [1] 96 💬 |
40 |
Blood sample |
- |
- |
- |
- |
008 [13] 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
41 |
Blood sample and environmental survey |
- |
- |
- |
- |
002 [1] 2 💬 |
42 |
Blood sample collection |
- |
- |
- |
- |
085 [1] 85 💬 |
43 |
Blood samples |
- |
- |
- |
- |
013 [8] 13, 41, 46, 51, 61, 97, 227, 271 💬 |
44 |
Blood sampling |
- |
- |
- |
- |
013 [5] 13, 17, 19, 51, 96 💬 |
45 |
Bnp blood sample test |
- |
- |
- |
- |
058 [1] 58 💬 |
46 |
Bortezomib/dexamethasone |
Bortezomib |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
283 [1] 283 💬 |
47 |
Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone |
Bortezomib |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 [1] 28 💬 |
48 |
Botox 200u in normal saline |
- |
- |
- |
- |
226 [1] 226 💬 |
49 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
[14] D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A [15] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
50 |
Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine. |
Busulfan |
[6] D00184 D00184, D00248 D00248, D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
PPP3CA [6] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 |
Alzheimer disease [37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [2] 60, 285 💬 |
51 |
Calcitonin (salmon) |
Salmon, unspecified |
- |
- |
- |
225 [1] 225 💬 |
52 |
Calcitonin nasal spray (salmon) |
Salmon, unspecified |
- |
- |
- |
096 [2] 96, 97 💬 |
53 |
Calcium carbonate |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
013 [8] 13, 19, 46, 53, 75, 96, 235, 299 💬 |
54 |
Calcium carbonate and alphacalcidol |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
235 [1] 235 💬 |
55 |
Calcium carbonate d |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
053 [1] 53 💬 |
56 |
Cannabis based medicine extract (sativex) |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
57 |
Cannabis sativa extract oromucosal spray |
Medical Cannabis |
- |
- |
- |
002 [1] 2 💬 |
58 |
Cas # in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
254 [1] 254 💬 |
59 |
Cas# in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
254 [1] 254 💬 |
60 |
Cevimeline |
Cevimeline |
[2] D00661 D00661, D07667 D07667 💬 |
CHRM3 [1] CHRM3 💬 |
Alzheimer disease [11] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
053 [1] 53 💬 |
61 |
Chf6333 (part 1 - sad) |
- |
- |
- |
- |
299 [1] 299 💬 |
62 |
Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine |
Azathioprine |
[12] D00238 D00238, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994, D03033 D03033 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
63 |
Combination therapy with vigabatrin and prednisolone |
Prednisolone |
[9] D00472 D00472, D00535 D00535, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
ABAT [2] ABAT, NR3C1 💬 |
Alanine, aspartate and glutamate metabolism [8] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 [1] 145 💬 |
64 |
Control group 0.9% isotonic saline |
- |
- |
- |
- |
299 [1] 299 💬 |
65 |
Control intervention (no dexamethasone) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
66 |
Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) |
Acetate |
[21] D00088 D00088, D00292 D00292, D00472 D00472, D00473 D00473, D00973 D00973, D00975 D00975, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D01998 D01998, D02156 D02156, D02174 D02174, D02591 D02591, D02592 D02592, D03301 D03301, D07749 D07749 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
67 |
Cosyntropin injectable suspension 1 mg/ml + vigabatrin |
Tetracosactide |
[2] D00284 D00284, D00535 D00535 💬 |
ABAT [2] ABAT, MC2R 💬 |
Alanine, aspartate and glutamate metabolism [12] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway |
145 [1] 145 💬 |
68 |
Culture of lymphoblastoid line from blood sample |
- |
- |
- |
- |
102 [1] 102 💬 |
69 |
Cyclophosphamide, bortezomib, and dexamethasone (cybord) |
Bortezomib |
[12] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 [1] 28 💬 |
70 |
Cyclophosphamide, bortezomib, dexamethasone |
Bortezomib |
[12] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760 💬 |
NR3C1 [2] NR3C1, PSMB5 💬 |
Alzheimer disease [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 [1] 28 💬 |
71 |
Cyclophosphamide, bortezomib, dexamethasone plus daratumumab |
Bortezomib |
[13] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760, D10777 D10777 💬 |
CD38 [3] CD38, NR3C1, PSMB5 💬 |
Alzheimer disease [16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia |
028 [1] 28 💬 |
72 |
Cyclophosphamide,cyclosporine a |
Cyclophosphamide |
[3] D00184 D00184, D00287 D00287, D07760 D07760 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
73 |
Cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [35] 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
74 |
Cyclosporine (gengraf ) |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
75 |
Cyclosporine (usan) |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
097 [1] 97 💬 |
76 |
Cyclosporine 5 mg/kg bid days 0-14 |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 [2] 38, 39 💬 |
77 |
Cyclosporine a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 [10] 19, 20, 36, 49, 50, 53, 58, 60, 234, 283 💬 |
78 |
Cyclosporine a (csa) |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 [2] 19, 60 💬 |
79 |
Cyclosporine a dry powder inhalation (drug) |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
80 |
Cyclosporine combine with mycophenolate mofetil |
Cyclosporine |
[5] D00184 D00184, D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [7] IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [35] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
283 [1] 283 💬 |
81 |
Cyclosporine inhalation solution |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
82 |
Cyclosporine inhalation solution (cis) |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
83 |
Cyclosporine oral product |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
84 |
Cyclosporine pill |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
056 [1] 56 💬 |
85 |
Cyclosporine vs infliximab |
Cyclosporine |
[2] D00184 D00184, D02598 D02598 💬 |
PPP3CA [6] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [84] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway |
097 [1] 97 💬 |
86 |
Cyclosporine-a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
095 [1] 95 💬 |
87 |
Device: 30-hour ambulatory sampling of intestinal fluid |
- |
- |
- |
- |
083 [1] 83 💬 |
88 |
Device: cyclosporine a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 [2] 19, 20 💬 |
89 |
Device: dexamethasone injection |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
090 [1] 90 💬 |
90 |
Device: frequently sampled oral glucose tolerance test and cgm |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
91 |
Device: oxygen saturation |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
084 [1] 84 💬 |
92 |
Dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
93 |
Dexamethasone (1 cycle) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
94 |
Dexamethasone (4 cycles) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
95 |
Dexamethasone (50mg 1dd6, 3 consecutive days/month) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [1] 35 💬 |
96 |
Dexamethasone 0,1 mg tablets |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
97 |
Dexamethasone 0,5mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
98 |
Dexamethasone 0.5mg tablet |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
99 |
Dexamethasone 0.5mg/5ml solution |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [2] 35, 162 💬 |
100 |
Dexamethasone 0.5mg/5ml solution in mucolox™ |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
035 [2] 35, 162 💬 |
101 |
Dexamethasone 1,5 mg tablets |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
102 |
Dexamethasone 21-dihydrogen phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [1] 65 💬 |
103 |
Dexamethasone 21-phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
104 |
Dexamethasone 2mg tablets |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
105 |
Dexamethasone 4 mg jenapharm |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
028 [1] 28 💬 |
106 |
Dexamethasone abcur |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
107 |
Dexamethasone and rituximab |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
108 |
Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland). |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
235 [1] 235 💬 |
109 |
Dexamethasone parotid irrigation |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
053 [1] 53 💬 |
110 |
Dexamethasone sodium phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [3] 65, 70, 96 💬 |
111 |
Dexamethasone sodium phosphate 250 mg/ 10 ml |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
112 |
Dexamethasone sodium phosphate 250 mg/10 ml solution |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
299 [1] 299 💬 |
113 |
Dexamethasone sodium phosphate ph. eur. |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
065 [1] 65 💬 |
114 |
Dexamethasone sodium sulfate |
Dexamethasone |
[11] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01732 D01732, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D05877 D05877 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
028 [1] 28 💬 |
115 |
Dexamethasone soduim phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
116 |
Dexamethasone, 40 mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
028 [1] 28 💬 |
117 |
Dextran sodium sulfur salt 5, mw 5 kda. a type of low molecular weight dextran sulfate (lmw-ds) |
Dextran |
[1] D00060 D00060 💬 |
- |
- |
002 [1] 2 💬 |
118 |
Diagnostic test: auto-assessment manikins (sam) |
- |
- |
- |
- |
006 [1] 6 💬 |
119 |
Diagnostic test: blood sample , doppler of uterine vessel and placenta |
- |
- |
- |
- |
288 [1] 288 💬 |
120 |
Diagnostic test: dexamethasone test |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
121 |
Diagnostic test: iontophoresis sessions in forearm of subjects with pilocarpine |
Pilocarpine |
[3] D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
299 [1] 299 💬 |
122 |
Diagnostic test: saliva swab |
- |
- |
- |
- |
075 [1] 75 💬 |
123 |
Diphenhydramine |
Diphenhydramine |
[6] D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 [8] 11, 49, 51, 70, 86, 96, 222, 256 💬 |
124 |
Diphenhydramine hydrochloride |
Diphenhydramine |
[6] D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 [1] 11 💬 |
125 |
Dipotassium salt |
- |
- |
- |
- |
046 [1] 46 💬 |
126 |
Donepezil sandoz |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
127 |
Dried blood spot (dbs) sampling |
- |
- |
- |
- |
019 [1] 19 💬 |
128 |
Drug: salirumab |
- |
- |
- |
- |
046 [1] 46 💬 |
129 |
Edoxaban |
Edoxaban |
[2] D09546 D09546, D09710 D09710 💬 |
F10 [1] F10 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
046 [2] 46, 88 💬 |
130 |
Erythromycin |
Erythromycin |
[9] D00140 D00140, D00851 D00851, D01361 D01361, D02009 D02009, D02184 D02184, D02523 D02523, D02524 D02524, D02525 D02525, D04054 D04054 💬 |
- |
- |
006 [5] 6 , 36, 164, 228, 291 💬 |
131 |
Etanercepet, rituximab, abatacept, tocilizumab, sarilumab |
Abatacept |
[4] D02596 D02596, D02994 D02994, D03203 D03203, D10161 D10161 💬 |
CD80 [4] CD80, CD86, IL6R, MS4A1 💬 |
Allograft rejection [24] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
132 |
Extra blood draw samples |
- |
- |
- |
- |
300 [1] 300 💬 |
133 |
Faecal sampling |
- |
- |
- |
- |
046 [1] 46 💬 |
134 |
Flucloxacillin |
Flucloxacillin |
[3] D01249 D01249, D04196 D04196, D07965 D07965 💬 |
- |
- |
299 [1] 299 💬 |
135 |
Flucloxacillin 250mg/5ml sugar-free powder for oral solution |
Flucloxacillin |
[3] D01249 D01249, D04196 D04196, D07965 D07965 💬 |
- |
- |
299 [1] 299 💬 |
136 |
Flucloxacillin sodium |
Flucloxacillin |
[3] D01249 D01249, D04196 D04196, D07965 D07965 💬 |
- |
- |
299 [1] 299 💬 |
137 |
Fluoxetine |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [4] 13, 17, 78, 86 💬 |
138 |
Fluoxetine hydrochloride |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [1] 13 💬 |
139 |
Forlax 4 g, poudre pour solution buvable en sachet |
- |
- |
- |
- |
299 [1] 299 💬 |
140 |
Gallium-68-dota-n-octreotide |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 [1] 84 💬 |
141 |
Genetic: blood or saliva sample collection |
- |
- |
- |
- |
299 [1] 299 💬 |
142 |
Glycerol/saline |
Glycerin |
[1] D00028 D00028 💬 |
- |
- |
316 [2] 316, 317 💬 |
143 |
Gm-csf (granulocyte-macrophage colony-stimulating factor, sargramostim) |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
229 [1] 229 💬 |
144 |
Gm-csf [leukine (sargramostim)] |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
229 [1] 229 💬 |
145 |
Green tea leaf |
Green tea leaf |
[1] D06903 D06903 💬 |
- |
- |
017 [1] 17 💬 |
146 |
Gsk1265744b (sodium salt) containing 14c-gsk1265744b |
- |
- |
- |
- |
265 [1] 265 💬 |
147 |
Gz/sar402671 |
- |
- |
- |
- |
006 [2] 6 , 19 💬 |
148 |
Gz402671 / sar402671 |
- |
- |
- |
- |
019 [1] 19 💬 |
149 |
Herbal treatment (sa100) |
- |
- |
- |
- |
097 [1] 97 💬 |
150 |
High dose dexamethasone pulses |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
151 |
Hypertonic saline |
- |
- |
- |
- |
299 [1] 299 💬 |
152 |
Hypertonic saline (7 %) and isotonic saline (0.9%) |
- |
- |
- |
- |
299 [1] 299 💬 |
153 |
Hypertonic saline (7%) |
- |
- |
- |
- |
299 [1] 299 💬 |
154 |
Hypertonic saline 6% - |
- |
- |
- |
- |
299 [1] 299 💬 |
155 |
Hypertonic saline 7% |
- |
- |
- |
- |
299 [1] 299 💬 |
156 |
Hypertonic saline solution |
- |
- |
- |
- |
299 [1] 299 💬 |
157 |
Ibuprofen sandoz 400 mg filmtabletten |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
158 |
Iloprost sale di trometamolo |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [1] 51 💬 |
159 |
Incb028050 phosphate salt |
Phosphate ion |
- |
- |
- |
046 [1] 46 💬 |
160 |
Inhaled 7% hypertonic saline (hs) |
- |
- |
- |
- |
299 [1] 299 💬 |
161 |
Inhaled hypertonic saline (7%) |
- |
- |
- |
- |
299 [1] 299 💬 |
162 |
Injection of normal saline |
- |
- |
- |
- |
006 [1] 6 💬 |
163 |
Intraarticular dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
164 |
Intravenous dexamethasone 1 mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
165 |
Iron sucrose |
Iron sucrose |
[2] D00025 D00025, D04616 D04616 💬 |
- |
- |
062 [3] 62, 96, 97 💬 |
166 |
Isatuximab |
Isatuximab |
[1] D11050 D11050 💬 |
CD38 [1] CD38 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
028 [2] 28, 61 💬 |
167 |
Isatuximab sar650984 |
Isatuximab |
[1] D11050 D11050 💬 |
CD38 [1] CD38 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
061 [1] 61 💬 |
168 |
Isotonic saline |
- |
- |
- |
- |
299 [1] 299 💬 |
169 |
Isotonic saline 0.9% |
- |
- |
- |
- |
299 [1] 299 💬 |
170 |
Jinarc - tolvaptan tablets |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
171 |
Kuvan® (sapropterin dihydrochloride) |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
240 [1] 240 💬 |
172 |
Lactobacillus salivarius ucc118 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
173 |
Lademirsen (sar339375) |
- |
- |
- |
- |
218 [1] 218 💬 |
174 |
Leflunomide-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
[3] D00448 D00448, D00749 D00749, D08050 D08050 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
046 [1] 46 💬 |
175 |
Lenalidomide and dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [1] 16 💬 |
176 |
Lenalidomide+dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [1] 16 💬 |
177 |
Lenalidomide, dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [1] 16 💬 |
178 |
Lenalidomide, dexamethasone and cyclophosphamide |
Cyclophosphamide |
[12] D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687, D07760 D07760 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [1] 28 💬 |
179 |
Leucovorin |
Leucovorin |
[3] D01211 D01211, D07986 D07986, D07987 D07987 💬 |
- |
- |
019 [2] 19, 46 💬 |
180 |
Lingzhi and sen miao san |
- |
- |
- |
- |
046 [1] 46 💬 |
181 |
Liposomal aerosol cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
182 |
Liposomal cyclosporine a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
183 |
Liposomal cyclosporine a 10 mg |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
184 |
Liposomal cyclosporine a 5 mg |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
185 |
Liraglutide |
Liraglutide |
[1] D06404 D06404 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [3] 6 , 75, 193 💬 |
186 |
Long term follow up in all patients who received sar422459 in previous study tdu13583 |
- |
- |
- |
- |
301 [1] 301 💬 |
187 |
Lys-saf302 |
- |
- |
- |
- |
019 [1] 19 💬 |
188 |
Me2125 (safinamide mesilate) |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
189 |
Melphalan, thalidomide and dexamethasone |
Dexamethasone |
[11] D00292 D00292, D00369 D00369, D00754 D00754, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [1] 28 💬 |
190 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
191 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
192 |
Metformine sandoz 850 mg filmomhulde tabletten |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
081 [1] 81 💬 |
193 |
Methotrexate + salazopyrine + hydroxychloroquine administration |
Hydroxychloroquine |
[3] D00142 D00142, D02115 D02115, D08050 D08050 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
194 |
Methotrexate plus sulfasalazine |
Methotrexate |
[3] D00142 D00142, D00448 D00448, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
195 |
Methotrexate, leucovorin and bms-986142 |
BMS-986142 |
[5] D00142 D00142, D01211 D01211, D02115 D02115, D07986 D07986, D07987 D07987 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
196 |
Methotrexate-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
[4] D00142 D00142, D00448 D00448, D02115 D02115, D08050 D08050 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
197 |
Metotrexato sandoz - 2.5 mg compresse 50 compresse in flacone pp |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
198 |
Mmf and dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
222 [1] 222 💬 |
199 |
Nabiximols |
Nabiximols |
[1] D09317 D09317 💬 |
- |
- |
013 [1] 13 💬 |
200 |
Nabiximols - sativex |
Nabiximols |
[1] D09317 D09317 💬 |
- |
- |
013 [1] 13 💬 |
201 |
Nebulized combination ipratropium bromide with salbutamol |
Ipratropium |
[2] D02147 D02147, D02212 D02212 💬 |
ADRB2 [6] ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Adrenergic signaling in cardiomyocytes [17] Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
202 |
Normal saline |
- |
- |
- |
- |
006 [16] 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
203 |
Normal saline 0.9% infusion solution |
- |
- |
- |
- |
022 [1] 22 💬 |
204 |
Normal saline enema |
- |
- |
- |
- |
097 [1] 97 💬 |
205 |
Normal saline for injection |
- |
- |
- |
- |
013 [1] 13 💬 |
206 |
Normal saline instillation |
- |
- |
- |
- |
226 [1] 226 💬 |
207 |
Normal saline iv, salt tablets |
- |
- |
- |
- |
299 [1] 299 💬 |
208 |
Normal saline solution |
- |
- |
- |
- |
299 [1] 299 💬 |
209 |
Normal saline: |
- |
- |
- |
- |
299 [1] 299 💬 |
210 |
Nsaids and sulfasalazine |
Sulfasalazine |
[1] D00448 D00448 💬 |
- |
- |
271 [1] 271 💬 |
211 |
Octreotide |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [7] 67, 75, 84, 85, 89, 193, 227 💬 |
212 |
Octreotide acetate |
Acetate |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
227 [1] 227 💬 |
213 |
Octreotide lar |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [2] 67, 227 💬 |
214 |
Octreotide lar / sandostatin lar (lar=long acting release) |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 [1] 84 💬 |
215 |
Octreotide-lar |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [1] 67 💬 |
216 |
One additional blood sample during a planned blood test |
- |
- |
- |
- |
266 [1] 266 💬 |
217 |
Opc-41061 (tolvaptan) |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
218 |
Oral cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
219 |
Oral erythromycin |
Erythromycin |
[9] D00140 D00140, D00851 D00851, D01361 D01361, D02009 D02009, D02184 D02184, D02523 D02523, D02524 D02524, D02525 D02525, D04054 D04054 💬 |
- |
- |
036 [1] 36 💬 |
220 |
Orfiril saft |
- |
- |
- |
- |
003 [1] 3 💬 |
221 |
Other: antigen (wheat base soy sauce) spray |
Wheat |
[1] D06902 D06902 💬 |
- |
- |
098 [1] 98 💬 |
222 |
Other: biological samples |
- |
- |
- |
- |
206 [1] 206 💬 |
223 |
Other: blood sample |
- |
- |
- |
- |
299 [1] 299 💬 |
224 |
Other: blood sample and cotton skin swabs |
Cotton |
- |
- |
- |
162 [1] 162 💬 |
225 |
Other: blood samples |
- |
- |
- |
- |
093 [1] 93 💬 |
226 |
Other: blood sampling for laboratory developed test (ldt) analysis |
- |
- |
- |
- |
065 [1] 65 💬 |
227 |
Other: bronchoalveolar samples |
- |
- |
- |
- |
051 [1] 51 💬 |
228 |
Other: collection of csf, blood, urine, saliva |
- |
- |
- |
- |
006 [1] 6 💬 |
229 |
Other: continuation of hypertonic saline (hs) |
- |
- |
- |
- |
299 [1] 299 💬 |
230 |
Other: control group(normal saline) |
- |
- |
- |
- |
097 [1] 97 💬 |
231 |
Other: discontinuation of hypertonic saline (hs) |
- |
- |
- |
- |
299 [1] 299 💬 |
232 |
Other: empiric use of calcium carbonate and calcitriol |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
233 |
Other: inhalable hypertonic saline 7% |
- |
- |
- |
- |
299 [1] 299 💬 |
234 |
Other: inhalable hypertonic saline 7% + hyaluronan 0.1% |
Hyaluronic acid |
[1] D08043 D08043 💬 |
- |
- |
299 [1] 299 💬 |
235 |
Other: intrathecal saline injection |
- |
- |
- |
- |
013 [1] 13 💬 |
236 |
Other: iv saline infusion |
- |
- |
- |
- |
096 [1] 96 💬 |
237 |
Other: joint mobilizations (spine, sacroiliac, hip) |
- |
- |
- |
- |
070 [1] 70 💬 |
238 |
Other: normal saline |
- |
- |
- |
- |
013 [4] 13, 222, 226, 280 💬 |
239 |
Other: normal saline for injection |
- |
- |
- |
- |
084 [1] 84 💬 |
240 |
Other: pth based calcium carbonate and calcitriol repletion |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
241 |
Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry. |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
149 [1] 149 💬 |
242 |
Other: salbutamol nebulisation and with cpap |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
243 |
Other: saline |
- |
- |
- |
- |
002 [8] 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
244 |
Other: saline as a nasal spray |
- |
- |
- |
- |
226 [1] 226 💬 |
245 |
Other: saline solution |
- |
- |
- |
- |
067 [1] 67 💬 |
246 |
Other: saline solution. |
- |
- |
- |
- |
067 [1] 67 💬 |
247 |
Other: sputum sample |
- |
- |
- |
- |
299 [1] 299 💬 |
248 |
Other: sterile normal saline (0.9% nacl) |
- |
- |
- |
- |
231 [1] 231 💬 |
249 |
Other: sterile saline |
- |
- |
- |
- |
046 [1] 46 💬 |
250 |
Other: stool sample |
- |
- |
- |
- |
006 [2] 6 , 299 💬 |
251 |
Other: subconjunctival injection of saline |
- |
- |
- |
- |
090 [1] 90 💬 |
252 |
Other: vehicle (d5w or saline) |
- |
- |
- |
- |
066 [1] 66 💬 |
253 |
Oxycodone depot ”sandoz”, depot tablets |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
298 [1] 298 💬 |
254 |
Pd00377 na-salt |
- |
- |
- |
- |
085 [1] 85 💬 |
255 |
Pentasa 2g sachet prolonged release granules (95%) |
- |
- |
- |
- |
097 [1] 97 💬 |
256 |
Pentasa sachet |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
257 |
Pentasa sachet 1 g |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
258 |
Pentasa sachet 1 g prolonged release granules |
- |
- |
- |
- |
096 [1] 96 💬 |
259 |
Pentasa sachet 1g |
- |
- |
- |
- |
097 [1] 97 💬 |
260 |
Pentasa sachet 2 g |
- |
- |
- |
- |
097 [1] 97 💬 |
261 |
Peri-neural dexamethasone 1 mg |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
262 |
Phosphate sandoz |
Phosphate ion |
- |
- |
- |
078 [1] 78 💬 |
263 |
Phosphate-buffered saline |
Phosphate ion |
- |
- |
- |
049 [1] 49 💬 |
264 |
Physiological saline |
- |
- |
- |
- |
051 [1] 51 💬 |
265 |
Pilocarpine |
Pilocarpine |
[3] D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [3] 6 , 53, 299 💬 |
266 |
Pilocarpine hydrochloride |
Pilocarpine |
[3] D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
053 [1] 53 💬 |
267 |
Pilocarpine nitrate 5% |
Nitrate |
[4] D00525 D00525, D02200 D02200, D02313 D02313, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
299 [1] 299 💬 |
268 |
Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
269 |
Placebo (physiological saline) |
- |
- |
- |
- |
043 [2] 43, 45 💬 |
270 |
Pnu-215062 sodium salt |
- |
- |
- |
- |
013 [1] 13 💬 |
271 |
Pomalidomide and dexamethasone |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D08976 D08976 💬 |
IL6 [3] IL6, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [79] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [1] 28 💬 |
272 |
Procedure: 2 ml of whole blood sample will be collected on edta tube |
Edetic acid |
[8] D00052 D00052, D00571 D00571, D01802 D01802, D03943 D03943, D03944 D03944, D03945 D03945, D03946 D03946, D03947 D03947 💬 |
- |
- |
051 [1] 51 💬 |
273 |
Procedure: biofluid samplings |
- |
- |
- |
- |
006 [1] 6 💬 |
274 |
Procedure: blood sample |
- |
- |
- |
- |
065 [1] 65 💬 |
275 |
Procedure: blood sampling for determination of serum zn |
- |
- |
- |
- |
299 [1] 299 💬 |
276 |
Procedure: blood sampling from infant |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
277 |
Procedure: blood sampling from mother |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
278 |
Procedure: blood sampling from umbilical cord |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
279 |
Procedure: blood sampling, endoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
280 |
Procedure: breast milk sampling |
- |
- |
- |
- |
046 [3] 46, 96, 271 💬 |
281 |
Procedure: endoscopic repair of myelomeningocele before 26 sa |
- |
- |
- |
- |
118 [1] 118 💬 |
282 |
Procedure: epidural steroid (dexamethasone) injection |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
283 |
Procedure: infusion of saline |
- |
- |
- |
- |
097 [1] 97 💬 |
284 |
Procedure: injection of salivary glands |
- |
- |
- |
- |
002 [1] 2 💬 |
285 |
Procedure: iv deployment of csvf in sterile normal saline iv solution |
- |
- |
- |
- |
085 [2] 85, 229 💬 |
286 |
Procedure: minor salivary gland (labial) biopsy |
- |
- |
- |
- |
053 [1] 53 💬 |
287 |
Procedure: pilocarpine |
Pilocarpine |
[3] D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
053 [1] 53 💬 |
288 |
Procedure: saline injection |
- |
- |
- |
- |
113 [1] 113 💬 |
289 |
Procedure: skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 srt patients included. |
- |
- |
- |
- |
102 [1] 102 💬 |
290 |
Procedure: spleen sample |
- |
- |
- |
- |
061 [1] 61 💬 |
291 |
Procedure: stool samples |
- |
- |
- |
- |
097 [1] 97 💬 |
292 |
Procedure: tissue samplings |
- |
- |
- |
- |
006 [1] 6 💬 |
293 |
R-hgh liquid (saizen) |
- |
- |
- |
- |
078 [1] 78 💬 |
294 |
R-salbutamol |
Levosalbutamol |
[2] D02147 D02147, D08124 D08124 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 [1] 49 💬 |
295 |
R-salbutamol sulphate |
Levosalbutamol |
[2] D02147 D02147, D08124 D08124 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 [1] 49 💬 |
296 |
Rabbit atg, cyclosporine, levamisole |
Antithymocyte immunoglobulin (rabbit) |
[3] D00184 D00184, D00750 D00750, D08114 D08114 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
297 |
Reduced glutathione sodium salt |
Glutathione |
[2] D00014 D00014, D00031 D00031 💬 |
- |
- |
299 [1] 299 💬 |
298 |
Regn475/sar164877 |
- |
- |
- |
- |
298 [1] 298 💬 |
299 |
Rhudex 100 mg (127 mg rhudex choline salt) granules |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
300 |
Rhudex 25 mg (31.75 mg rhudex choline salt) granules |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
301 |
Rhudex 50 mg (63.5 mg rhudex choline salt) granules |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
302 |
Rhudex choline salt |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
303 |
Ropivacaine plus normal saline |
Ropivacaine |
[2] D04048 D04048, D08490 D08490 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
070 [1] 70 💬 |
304 |
S-adenosyl-methionine (same) capsules |
Ademetionine |
[3] D00019 D00019, D04983 D04983, D07128 D07128 💬 |
- |
- |
093 [1] 93 💬 |
305 |
Sa |
- |
- |
- |
- |
006 [5] 6 , 30, 60, 118, 298 💬 |
306 |
Sa-001 |
- |
- |
- |
- |
298 [1] 298 💬 |
307 |
Sa237 |
- |
- |
- |
- |
013 [1] 13 💬 |
308 |
Sabril |
- |
- |
- |
- |
145 [1] 145 💬 |
309 |
Sabril granules for oral use |
- |
- |
- |
- |
145 [1] 145 💬 |
310 |
Sabril sachets |
- |
- |
- |
- |
145 [1] 145 💬 |
311 |
Sabrilex |
- |
- |
- |
- |
145 [1] 145 💬 |
312 |
Sabril® |
- |
- |
- |
- |
145 [1] 145 💬 |
313 |
Saccharomyces |
- |
- |
- |
- |
051 [1] 51 💬 |
314 |
Saccharomyces boulardii oral tablet |
- |
- |
- |
- |
051 [1] 51 💬 |
315 |
Sacubitril |
Sacubitril |
[1] D10225 D10225 💬 |
MME [1] MME 💬 |
Alzheimer disease [4] Alzheimer disease, Hematopoietic cell lineage, Protein digestion and absorption, Renin-angiotensin system |
058 [1] 58 💬 |
316 |
Sacubitril valsartan |
Sacubitril |
[2] D00400 D00400, D10225 D10225 💬 |
AGTR1 [2] AGTR1, MME 💬 |
AGE-RAGE signaling pathway in diabetic complications [19] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
317 |
Sacubitril/valsartan |
Sacubitril |
[2] D00400 D00400, D10225 D10225 💬 |
AGTR1 [2] AGTR1, MME 💬 |
AGE-RAGE signaling pathway in diabetic complications [19] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
318 |
Saf-301 |
- |
- |
- |
- |
019 [1] 19 💬 |
319 |
Safety observation |
- |
- |
- |
- |
006 [1] 6 💬 |
320 |
Saffron supplementation |
- |
- |
- |
- |
301 [1] 301 💬 |
321 |
Safinamida |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
322 |
Safinamide |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
323 |
Safinamide (as add-on therapy) |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
324 |
Safinamide + levodopa |
Levodopa |
[2] D00059 D00059, D10158 D10158 💬 |
DRD1 [6] DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬 |
Alcoholism [20] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
325 |
Safinamide metansolfonato |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
326 |
Safinamide metansolfonato (12 weeks) |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
327 |
Safinamide methanesulfonate |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
328 |
Safinamide methanesulfonate 100mg |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
329 |
Safinamide methanesulfonate 150mg |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
330 |
Safinamide methansulfonate |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
331 |
Safinamide, mao-b inhibitor |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
332 |
Safinimide 50-100 mg/day |
- |
- |
- |
- |
006 [1] 6 💬 |
333 |
Sage |
Sage |
- |
- |
- |
006 [1] 6 💬 |
334 |
Sage leaf |
Sage |
- |
- |
- |
006 [1] 6 💬 |
335 |
Sage-217 |
- |
- |
- |
- |
006 [1] 6 💬 |
336 |
Sage-718 |
- |
- |
- |
- |
006 [2] 6 , 8 💬 |
337 |
Sait101 |
- |
- |
- |
- |
046 [1] 46 💬 |
338 |
Sait101 (proposed rituximab biosimilar) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
339 |
Sait101 (rituximab biosimilar) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [1] 46 💬 |
340 |
Saizen |
- |
- |
- |
- |
078 [1] 78 💬 |
341 |
Saizen 8mg click.easy powder for solution for injection |
- |
- |
- |
- |
078 [1] 78 💬 |
342 |
Saizen 8mg click.easy power for solution for injection |
- |
- |
- |
- |
078 [1] 78 💬 |
343 |
Saizen® |
- |
- |
- |
- |
078 [1] 78 💬 |
344 |
Saizen® solution for injection (referred as saizen®) |
- |
- |
- |
- |
078 [1] 78 💬 |
345 |
Salazopyrin |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
346 |
Salazopyrin en |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
347 |
Salazopyrin en 500 mg enterotabletter |
- |
- |
- |
- |
046 [1] 46 💬 |
348 |
Salazopyrin en-tabs |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
349 |
Salazopyrine |
- |
- |
- |
- |
046 [1] 46 💬 |
350 |
Salazosulfapyridine |
Sulfasalazine |
[1] D00448 D00448 💬 |
- |
- |
046 [1] 46 💬 |
351 |
Salbutamol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 [9] 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
352 |
Salbutamol 4mg tablet |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
353 |
Salbutamol sulfate |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
111 [1] 111 💬 |
354 |
Salbutamol sulfate ph. eur. |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
355 |
Salbutamol wzf 4 mg |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
356 |
Salicylazosulfapyridine |
Sulfasalazine |
[1] D00448 D00448 💬 |
- |
- |
271 [1] 271 💬 |
357 |
Salicylic acid |
Salicylic acid |
[1] D00097 D00097 💬 |
- |
- |
097 [1] 97 💬 |
358 |
Saline |
- |
- |
- |
- |
006 [10] 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
359 |
Saline 0.9% inhalation solution |
- |
- |
- |
- |
299 [1] 299 💬 |
360 |
Saline 0.9% nacl |
- |
- |
- |
- |
235 [1] 235 💬 |
361 |
Saline intranasal delivery |
- |
- |
- |
- |
006 [1] 6 💬 |
362 |
Saline nasal mist |
- |
- |
- |
- |
127 [1] 127 💬 |
363 |
Saline solution |
- |
- |
- |
- |
002 [4] 2 , 34, 288, 299 💬 |
364 |
Saline solution for injection |
- |
- |
- |
- |
019 [1] 19 💬 |
365 |
Salmeterol |
Salmeterol |
[2] D00687 D00687, D05792 D05792 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
299 [1] 299 💬 |
366 |
Salmon |
Salmon, unspecified |
- |
- |
- |
096 [3] 96, 97, 225 💬 |
367 |
Salofalk |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
368 |
Salofalk 1000mg granu-stix |
- |
- |
- |
- |
097 [1] 97 💬 |
369 |
Salofalk 1000mg granu-stix® |
- |
- |
- |
- |
097 [1] 97 💬 |
370 |
Salofalk 3g gastro-resistant prolonged-release granules |
- |
- |
- |
- |
097 [1] 97 💬 |
371 |
Salofalk 4g/60ml klysma |
- |
- |
- |
- |
097 [1] 97 💬 |
372 |
Salofalk 500 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
373 |
Salofalk granu-stix 500 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
374 |
Salofalk® 1000mg granu-stix® |
- |
- |
- |
- |
097 [1] 97 💬 |
375 |
Salofalk® 500 mg gastro-resistant tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
376 |
Salofalk® 500 mg tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
377 |
Salofalk® 500mg |
- |
- |
- |
- |
097 [1] 97 💬 |
378 |
Salofalk® 500mg granu-stix® |
- |
- |
- |
- |
097 [1] 97 💬 |
379 |
Salsalate |
Salsalate |
[1] D00428 D00428 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
005 [1] 5 💬 |
380 |
Sam |
- |
- |
- |
- |
006 [1] 6 💬 |
381 |
Sam-e |
Ademetionine |
[1] D07128 D07128 💬 |
- |
- |
006 [1] 6 💬 |
382 |
Same |
Ademetionine |
[1] D07128 D07128 💬 |
- |
- |
093 [1] 93 💬 |
383 |
Samsca |
- |
- |
- |
- |
067 [2] 67, 72 💬 |
384 |
Samsca 15 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
385 |
Samsca 30 mg tablets |
- |
- |
- |
- |
067 [1] 67 💬 |
386 |
Samsca*10cpr 15mg |
- |
- |
- |
- |
072 [1] 72 💬 |
387 |
San-300 |
- |
- |
- |
- |
046 [1] 46 💬 |
388 |
Sandimmum |
- |
- |
- |
- |
097 [1] 97 💬 |
389 |
Sandimmun |
- |
- |
- |
- |
097 [2] 97, 226 💬 |
390 |
Sandimmun 50 mg/ml, infuusiokonsentraatti |
- |
- |
- |
- |
097 [1] 97 💬 |
391 |
Sandimmun neoral |
- |
- |
- |
- |
060 [3] 60, 97, 226 💬 |
392 |
Sandimmun neoral*30cps 100mg |
- |
- |
- |
- |
046 [1] 46 💬 |
393 |
Sandimmun neoral*50cps 25mg |
- |
- |
- |
- |
046 [1] 46 💬 |
394 |
Sandimmun optoral |
- |
- |
- |
- |
053 [2] 53, 113 💬 |
395 |
Sandinum |
- |
- |
- |
- |
097 [1] 97 💬 |
396 |
Sandostatin lar |
- |
- |
- |
- |
067 [4] 67, 84, 193, 227 💬 |
397 |
Sandostatin lar 20 mg |
- |
- |
- |
- |
227 [1] 227 💬 |
398 |
Sandostatina |
- |
- |
- |
- |
067 [1] 67 💬 |
399 |
Sandostatina - lar 20 mg/2.5 ml polvere e solvente per sospensione iniettabile flacone polvere + siringa preriempita 2.5 ml + 2 aghi |
- |
- |
- |
- |
067 [1] 67 💬 |
400 |
Sandostatina lar |
- |
- |
- |
- |
067 [1] 67 💬 |
401 |
Sandostatina lar im fl 20mg +2f |
- |
- |
- |
- |
067 [1] 67 💬 |
402 |
Sandostatine |
- |
- |
- |
- |
096 [1] 96 💬 |
403 |
Sapropterin |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
086 [3] 86, 124, 240 💬 |
404 |
Sapropterin (kuvan) |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
240 [1] 240 💬 |
405 |
Sapropterin dihydrochloride |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
240 [1] 240 💬 |
406 |
Sapropterin dihydrochloride (6r-bh4) |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
086 [1] 86 💬 |
407 |
Sapropterin dihydrochloride, 6r-bh4, tetrahydrobiopterin |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
240 [1] 240 💬 |
408 |
Sapropterin dihydrocholoride |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
240 [1] 240 💬 |
409 |
Sapropterin hydrochloride |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
240 [1] 240 💬 |
410 |
Sapropterin, sapropterin dihydrochloride |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
240 [1] 240 💬 |
411 |
Sapropterin, sapropterin hydrochloride |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
240 [1] 240 💬 |
412 |
Sapropterindihydrochloride |
- |
- |
- |
- |
240 [1] 240 💬 |
413 |
Saproterin dihydrochloride |
- |
- |
- |
- |
240 [1] 240 💬 |
414 |
Saquinavir |
Saquinavir |
[2] D00429 D00429, D01160 D01160 💬 |
- |
- |
086 [2] 86, 265 💬 |
415 |
Saquinavir and ritonavir |
Ritonavir |
[3] D00427 D00427, D00429 D00429, D01160 D01160 💬 |
- |
- |
086 [1] 86 💬 |
416 |
Sar |
- |
- |
- |
- |
046 [1] 46 💬 |
417 |
Sar100842 |
- |
- |
- |
- |
051 [1] 51 💬 |
418 |
Sar113244 |
- |
- |
- |
- |
049 [1] 49 💬 |
419 |
Sar153191 |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 [4] 41, 46, 107, 271 💬 |
420 |
Sar153191 (regn88) |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [2] 46, 107 💬 |
421 |
Sar156597 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
422 |
Sar156597 (act14604) |
- |
- |
- |
- |
051 [1] 51 💬 |
423 |
Sar231893 |
- |
- |
- |
- |
051 [2] 51, 160 💬 |
424 |
Sar236553 |
- |
- |
- |
- |
079 [1] 79 💬 |
425 |
Sar339658 |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
426 |
Sar402671, gz402671 or gz/sar402671 |
- |
- |
- |
- |
006 [3] 6 , 19, 67 💬 |
427 |
Sar421869 |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
428 |
Sar422459 |
- |
- |
- |
- |
301 [1] 301 💬 |
429 |
Sar441344 |
- |
- |
- |
- |
053 [1] 53 💬 |
430 |
Sar442168 |
- |
- |
- |
- |
013 [1] 13 💬 |
431 |
Saracatinab |
- |
- |
- |
- |
085 [1] 85 💬 |
432 |
Saracatinib |
Saracatinib |
[1] D09664 D09664 💬 |
ABL1 [2] ABL1, SRC 💬 |
Adherens junction [46] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
006 [3] 6 , 89, 272 💬 |
433 |
Saracatinib difumarate |
Saracatinib |
[1] D09664 D09664 💬 |
ABL1 [2] ABL1, SRC 💬 |
Adherens junction [46] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
272 [1] 272 💬 |
434 |
Sarcosine |
Sarcosine |
- |
- |
- |
006 [1] 6 💬 |
435 |
Sarcosine capsule |
Sarcosine |
- |
- |
- |
006 [1] 6 💬 |
436 |
Sargramostim |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
006 [7] 6 , 28, 60, 62, 96, 229, 285 💬 |
437 |
Sargramostim (leukine) |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
096 [1] 96 💬 |
438 |
Sarilumab |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 [5] 41, 46, 84, 107, 271 💬 |
439 |
Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara] |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
440 |
Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara]_#1 |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
084 [1] 84 💬 |
441 |
Sarilumab sar153191 |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 [1] 41 💬 |
442 |
Sarilumab sar153191 (regn88) |
Sarilumab |
[1] D10161 D10161 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [2] 46, 107 💬 |
443 |
Sarizotan |
Sarizotan |
- |
- |
- |
006 [2] 6 , 156 💬 |
444 |
Sarizotan hc1 |
Sarizotan |
- |
- |
- |
006 [1] 6 💬 |
445 |
Sarizotan hcl |
Sarizotan |
- |
- |
- |
006 [1] 6 💬 |
446 |
Sarizotan hydrochloride |
Sarizotan |
- |
- |
- |
006 [2] 6 , 156 💬 |
447 |
Saroglitazar |
Saroglitazar |
- |
- |
- |
093 [1] 93 💬 |
448 |
Saroglitazar magnesium 2 mg |
Magnesium |
- |
- |
- |
093 [1] 93 💬 |
449 |
Saroglitazar magnesium 4 mg |
Magnesium |
- |
- |
- |
093 [1] 93 💬 |
450 |
Satavaptan |
Satavaptan |
- |
- |
- |
072 [1] 72 💬 |
451 |
Satavaptan (sr121463) |
Satavaptan |
- |
- |
- |
072 [1] 72 💬 |
452 |
Satavaptan (sr121463b) |
Satavaptan |
- |
- |
- |
072 [1] 72 💬 |
453 |
Sativex |
- |
- |
- |
- |
002 [2] 2 , 13 💬 |
454 |
Sativex oromucosal spray |
- |
- |
- |
- |
013 [1] 13 💬 |
455 |
Sativex oromucosal spray (non-marketed) |
- |
- |
- |
- |
013 [1] 13 💬 |
456 |
Sativex® |
- |
- |
- |
- |
013 [1] 13 💬 |
457 |
Satralizumab |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
458 |
Satralizumab (120 mg/pfs with nsd) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
459 |
Satralizumab (120 mg/vial) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
460 |
Satralizumab (120mg/vial) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
461 |
Satralizumab (r-inn) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
462 |
Satralizumab (ro5333787/enspryng /sa237) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
463 |
Satralizumab (ro5333787/enspryng/sa237) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
464 |
Satralizumab (ro5333787/sa237) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
465 |
Satrazlizumab (ro5333787/ enspryng /sa237) |
- |
- |
- |
- |
013 [1] 13 💬 |
466 |
Sauerstoff |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
467 |
Saxagliptin |
Saxagliptin |
[1] D08996 D08996 💬 |
DPP4 [1] DPP4 💬 |
Protein digestion and absorption [1] Protein digestion and absorption |
299 [1] 299 💬 |
468 |
Saxenda |
- |
- |
- |
- |
193 [1] 193 💬 |
469 |
Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group) |
Amitriptyline |
[7] D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D02691 D02691, D07448 D07448, D08623 D08623 💬 |
GHR [4] GHR, OPRM1, SLC6A2, SLC6A4 💬 |
Cytokine-cytokine receptor interaction [9] Cytokine-cytokine receptor interaction, Estrogen signaling pathway, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Serotonergic synapse, Synaptic vesicle cycle |
078 [1] 78 💬 |
470 |
Sc treatment with igsc, 10% with rhuph20 followed by iv/igsc, 10% only (safety) |
- |
- |
- |
- |
065 [1] 65 💬 |
471 |
Sc treatment with igsc, 10% with rhuph20 followed by sc/igsc, 10% only (safety) |
- |
- |
- |
- |
065 [1] 65 💬 |
472 |
Silikis 3µg/g salbe |
- |
- |
- |
- |
037 [1] 37 💬 |
473 |
Simvastatina sandoz 40 mg comprimidos recubiertos con película efg |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
474 |
Simvastatine sandoz 40 mg filmomhulde tabletten |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
475 |
Simvastatine sandoz 40mg deelbare filmomhulde tabletten |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
476 |
Sinvastatina sandoz 40 mg comprimidos revestidos por película |
- |
- |
- |
- |
013 [1] 13 💬 |
477 |
Sodium acid pyrophosphate sapp ror 28 food grade |
- |
- |
- |
- |
166 [1] 166 💬 |
478 |
Stavudine |
Stavudine |
[1] D00445 D00445 💬 |
- |
- |
265 [1] 265 💬 |
479 |
Sterile normal saline (0.9% nacl) |
- |
- |
- |
- |
062 [3] 62, 234, 254 💬 |
480 |
Sterile normal saline for intravenous use |
- |
- |
- |
- |
085 [2] 85, 229 💬 |
481 |
Sterile saline |
- |
- |
- |
- |
227 [1] 227 💬 |
482 |
Sterile saline for injection |
- |
- |
- |
- |
097 [1] 97 💬 |
483 |
Sterile saline solution |
- |
- |
- |
- |
051 [1] 51 💬 |
484 |
Strontium ranelate |
Strontium ranelate |
[1] D08468 D08468 💬 |
- |
- |
078 [1] 78 💬 |
485 |
Sulfasalazine |
Sulfasalazine |
[1] D00448 D00448 💬 |
- |
- |
046 [4] 46, 86, 94, 271 💬 |
486 |
Sulfasalazine, ssz |
Sulfasalazine |
[1] D00448 D00448 💬 |
- |
- |
271 [1] 271 💬 |
487 |
Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt) |
Hydrogen |
- |
- |
- |
006 [1] 6 💬 |
488 |
Teicoplanin sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. |
Teicoplanin |
[1] D02142 D02142 💬 |
- |
- |
299 [1] 299 💬 |
489 |
The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
490 |
Tocilizumab sc 162 mg/0.9 ml pre-filled syringe with safety device (pfs) |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
491 |
Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs) |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
051 [1] 51 💬 |
492 |
Tolvaptan |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [3] 67, 72, 225 💬 |
493 |
Tolvaptan (opc-41061) |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
494 |
Tolvaptan 15 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
495 |
Tolvaptan 15 mg tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
496 |
Tolvaptan 15 mg tablets |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
497 |
Tolvaptan 15mg |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
498 |
Tolvaptan 30 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
499 |
Tolvaptan 30 mg tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
500 |
Tolvaptan 30 mg tablets |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
501 |
Tolvaptan 30mg |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
502 |
Tolvaptan 45/15 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
503 |
Tolvaptan 60/30 |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
504 |
Tolvaptan 7.5 mg tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
505 |
Tolvaptan in euvolemic hyponatremia |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
072 [1] 72 💬 |
506 |
Tolvaptan ir |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
507 |
Tolvaptan mr |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
067 [1] 67 💬 |
508 |
Tolvaptan oral tablet |
Tolvaptan |
[1] D01213 D01213 💬 |
AVPR2 [1] AVPR2 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
072 [1] 72 💬 |
509 |
Trexan+salazopyrin+oxiklorin+prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
510 |
Trexan+salazopyrin+oxiklorin+prednisolone + infliximab |
Infliximab |
[9] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D02598 D02598, D03301 D03301 💬 |
NR3C1 [2] NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
511 |
Triamcinolone acetonide and normal saline solution |
Triamcinolone |
[5] D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
512 |
Twice-daily dosage with 0.5% cyclosporine-a eyedrops |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
090 [1] 90 💬 |
513 |
Uk: sativex oromucosal spray |
- |
- |
- |
- |
013 [1] 13 💬 |
514 |
Urine sample |
- |
- |
- |
- |
049 [3] 49, 51, 61 💬 |
515 |
Urine samples |
- |
- |
- |
- |
013 [1] 13 💬 |
516 |
Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
517 |
Ushstat (sar421869) |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
518 |
Venglustat (gz/sar402671) |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
519 |
Venglustat gz/sar402671 |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
067 [1] 67 💬 |
520 |
Venous blood sample |
- |
- |
- |
- |
046 [1] 46 💬 |
521 |
Vigabatrin |
Vigabatrin |
[1] D00535 D00535 💬 |
ABAT [1] ABAT 💬 |
Alanine, aspartate and glutamate metabolism [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 [2] 145, 158 💬 |
522 |
Vigabatrin (sabril) |
Vigabatrin |
[1] D00535 D00535 💬 |
ABAT [1] ABAT 💬 |
Alanine, aspartate and glutamate metabolism [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
158 [1] 158 💬 |
523 |
Vigabatrin tablets |
Vigabatrin |
[1] D00535 D00535 💬 |
ABAT [1] ABAT 💬 |
Alanine, aspartate and glutamate metabolism [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 [1] 145 💬 |
524 |
Vigabatrin: vigabatrin new st formulation then sabril® |
Vigabatrin |
[1] D00535 D00535 💬 |
ABAT [1] ABAT 💬 |
Alanine, aspartate and glutamate metabolism [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
145 [1] 145 💬 |
525 |
Vitamin: choline bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1 |
Choline |
[1] D07690 D07690 💬 |
- |
- |
299 [1] 299 💬 |
526 |
Vx-371 in hypertonic saline |
- |
- |
- |
- |
299 [1] 299 💬 |
527 |
Vx-371 in saline |
- |
- |
- |
- |
299 [1] 299 💬 |
528 |
Whole blood sample |
- |
- |
- |
- |
177 [1] 177 💬 |
529 |
Xadago (safinamide) |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
530 |
Zolpidem |
Zolpidem |
[2] D00706 D00706, D08690 D08690 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
005 [3] 5 , 6 , 46 💬 |
531 |
Zolpidem first dose |
Zolpidem |
[2] D00706 D00706, D08690 D08690 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
532 |
Zolpidem second dose |
Zolpidem |
[2] D00706 D00706, D08690 D08690 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
533 |
Zolpidem tartrate |
Zolpidem |
[2] D00706 D00706, D08690 D08690 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
534 |
lnp023 hydrochloride salt |
- |
- |
- |
- |
062 [3] 62, 66, 222 💬 |